Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -2.417.3270.7146.60-54.32

What is the latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is -2.41 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-2.41
Mar20237.32
Mar202270.71
Mar202146.60
Mar2020-54.32

How is EBIT Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 -2.41
Negative
Mar2023 7.32
-89.65
Mar2022 70.71
51.74
Mar2021 46.6
Positive
Mar2020 -54.32 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹47,265.1 Cr -2% 2.2% 35.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,971.0 Cr -4.6% 0.7% 10.8% Stock Analytics
DIVIS LABORATORIES ₹161,153.0 Cr -1.2% 12.6% 51.2% Stock Analytics
CIPLA ₹122,717.0 Cr 0.7% 6% 9.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,392.0 Cr -1.8% -0.4% 25.1% Stock Analytics
DR REDDYS LABORATORIES ₹100,702.0 Cr 4% 8.9% -1.3% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-2%

2.2%

35.2%

SENSEX

0.6%

11%

10.4%


You may also like the below Video Courses